Medications for Shift Work Sleep Disturbances

First-Line Pharmacological Options

The American Geriatrics Society recommends Modafinil as first-line therapy for excessive sleepiness associated with shift work sleep disorder, with typical doses ranging from 200-400 mg taken before the shift, and common side effects including nausea, headaches, and nervousness 1, 2
The National Comprehensive Cancer Network suggests Armodafinil as an alternative first-line agent that reduces sleepiness by approximately one point on the Karolinska Sleepiness Scale and improves alertness in patients with shift work sleep disorder 1

The American Geriatrics Society recommends traditional stimulants, such as Methylphenidate or dextroamphetamine, for refractory daytime sedation, starting at 2.5-5 mg orally with breakfast, and if needed, a second dose can be given at lunch (no later than 2:00 pm) 1, 2
The National Comprehensive Cancer Network suggests Caffeine can be used judiciously, with the last dose given no later than 4:00 pm, and when combined with pre-shift naps, caffeine has been shown to decrease sleepiness during night shifts 1

The American Geriatrics Society recommends maintaining good sleep hygiene and a regular sleep-wake schedule, allowing adequate time for sleep, and avoiding heavy meals throughout the day and alcohol use 2
The American Geriatrics Society suggests two short 15-20 minute naps, one around noon and another around 4:00-5:00 pm, may help alleviate sleepiness 2

The American Geriatrics Society recommends more frequent follow-up is necessary when starting medications or adjusting doses, and monitoring for adverse effects of stimulants, including hypertension, palpitations, arrhythmias, irritability, or behavioral manifestations such as psychosis 2
The American Geriatrics Society suggests regularly reassessing functional ability as medications like modafinil generally improve but do not eliminate sleepiness 2

The National Comprehensive Cancer Network recommends avoiding benzodiazepines in elderly patients or those with cognitive impairment, as they can cause decreased cognitive performance 1
The National Comprehensive Cancer Network suggests exercising caution when using zolpidem due to the risk of next-morning impairment, and lower doses are recommended by the FDA (5 mg for immediate-release products and 6.25 mg for extended-release formulations) 1
The American Geriatrics Society recommends occupational counseling may benefit patients who are still employed, with recommendations to avoid shift work if possible 2